In Reply to 'Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy'
Details
Serval ID
serval:BIB_AF35AC5F4C63
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
In Reply to 'Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy'
Journal
Am J Kidney Dis
ISSN
1523-6838 (Electronic)
ISSN-L
0272-6386
Publication state
Published
Issued date
12/2018
Volume
72
Number
6
Pages
906-907
Language
english
Notes
Le Quintrec, Moglie
Fremeaux-Bacchi, Veronique
Fakhouri, Fadi
eng
Letter
Comment
Am J Kidney Dis. 2018 Dec;72(6):906-907. doi: 10.1053/j.ajkd.2018.08.005. Epub 2018 Sep 17.
Fremeaux-Bacchi, Veronique
Fakhouri, Fadi
eng
Letter
Comment
Am J Kidney Dis. 2018 Dec;72(6):906-907. doi: 10.1053/j.ajkd.2018.08.005. Epub 2018 Sep 17.
Keywords
Antibodies, Monoclonal, Humanized, *Glomerulonephritis, Membranoproliferative, Humans, *Kidney Diseases, Standard of Care
Pubmed
Create date
01/03/2022 11:18
Last modification date
02/03/2022 7:36
Usage data
